Vicente Más

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

Laurent Detalle, Thomas Stöhr, Concepción Palomo et al. · Antimicrobial Agents and Chemotherapy · 2015 · 296 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus (VHSV)

Vicente Micol, Nuria Caturla, Vicente Más et al. · Antiviral Research · 2005 · 274 citations

Life Sciences, Infectious Diseases, Microbiology +13

Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention

Margarita Magro, Vicente Más, Keith J. Chappell et al. · Proceedings of the National Academy of Sciences · 2012 · 271 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors

Morgan S. A. Gilman, Carlos A. Castellanos, Man Chen et al. · Science Immunology · 2016 · 243 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

De novo protein design enables the precise induction of RSV-neutralizing antibodies

Fabian Sesterhenn, Che Yang, Jaume Bonet et al. · Science · 2020 · 204 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17